The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆
Open accessAbstract
BACKGROUND & AIMS: Significant improvements in management of hepatocellular carcinoma (HCC) have occurred in the last years, but their impact on surveillance outcome is unknown. To clarify this, we compared survival of HCC patients identified along 3 consecutive quinquennia of surveillance. METHODS: A cohort of 417 HCC-free outpatients with compensated cirrhosis was prospectively followed for 148 months (range, 1-213 months) with periodic ultrasound examinations. RESULTS: HCC developed in 112 patients, at a 3.4% rate per year, and was the prime cause of death (n = 54). Forty-six (41%) patients had a single tumor, with a mean size of 3.7 cm, 3.0 cm, and 2.2 cm in the 3 quinquennia (first vs. second: ns; first vs. third: P = 0.017; second vs. third: P = 0.02), and 38 (44%) underwent radical therapy. Mortality rates in HCC patients fell from 45% in the first quinquennium to 37% in the second and 10% in the third (first vs. second: ns; first vs. third: P = 0.0009; second vs. third: P = 0.018) in parallel with a reduction in yearly mortality of treated patients (34%, 28%, and 5%, respectively; first vs. second: ns; second vs. third: P = 0.036; first vs. third: P = 0.0024). After stratification for quinquennium, tumor staging, according to Cancer of the Liver Italian Program (CLIP), was the only independent predictor of survival (P = 0.015). CONCLUSIONS: Cirrhotic patients developing a HCC during the last 5 years of surveillance survived longer than previously, as a consequence of improved management of the tumor and complications of cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transection of the oesophagus for bleeding oesophageal varices
Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., Pietroni, M. C., & Williams, R. (1973) · Journal of British Surgery · doi:10.1002/bjs.1800600817 · Cited by 7,941 · cited 1×
“0 29 4 (40) 5 (83) 10 (45) 9 (47) 0 1 (2) 1 45 3 (30) 0 9 (41) 7 (37) 5 (45.5) 21 (48) 2 27 2 (20) 1 (17) 3 ( 14 ) 3 (16) 5 (45.5) 13 (30) 3 9 1 (10) 0 0 0 1 (9) 7 (16) 4 2 0 0 0 0 0 2 (4) All 112 10 (100) 6 (100) 22 (100) 19 (100) 11 (100) 44 (100)”
InfluentialMazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Self-citationClinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Self-citationSmall Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol Injection
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Solbiati, L., & Gazelle, G. S. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe40655 · Cited by 1,283
A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients
(1998) · Hepatology · doi:10.1002/hep.510280322 · Cited by 1,238
Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J., Visa, J., Bru, C., & Rodes, J. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70070-7 · Cited by 895
Hepatocellular Carcinoma in Italian Patients with Cirrhosis
Colombo, M., de Franchis, R., Del Ninno, E., Sangiovanni, A., De Fazio, C., Tommasini, M., Donato, M. F., Piva, A., Di Carlo, V., & Dioguardi, N. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109053251002 · Cited by 813
Self-citationTyping of hepatitis C virus isolates and characterization of new subtypes using a line probe assay
Stuyver, L., Rossau, R., Wyseur, A., Duhamel, M., Vanderborght, B., Van Heuverswyn, H., & Maertens, G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-6-1093 · Cited by 685
Bolondi, L., Sofia, S., Siringo, S., Gaiani, S., Casali, A., Zironi, G., Piscaglia, F., Gramantieri, L., Zanetti, M., & Sherman, M. (2001) · Gut · doi:10.1136/gut.48.2.251 · Cited by 643
Performance status assessment in cancer patients. An inter-observer variability study
Sørensen, J., Klee, M., Palshof, T., & Hansen, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.140 · Cited by 483
Prospective Analysis of Risk Factors for Hepatocellular Carcinoma in Patients With Liver Cirrhosis
Velázquez, R. F., Rodríguez, M., Navascués, C. A., Linares, A., Pérez, R., Sotorríos, N. G., Martínez, I., & Rodrigo, L. (2003) · Hepatology · doi:10.1053/jhep.2003.50093 · Cited by 440
Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
Yuen, M.-F., Cheng, C.-C., Lauder, I. J., Lam, S.-K., Ooi, C. G., & Lai, C.-L. (2000) · Hepatology · doi:10.1002/hep.510310211 · Cited by 411
Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis
Oka, H., Kurioka, N., Kim, K., Kanno, T., Kuroki, T., Mizoguchi, Y., & Kobayashi, K. (1990) · Hepatology · doi:10.1002/hep.1840120411 · Cited by 392
Performance status assessment in cancer patients
Conill, C., Verger, E., & Salamero, M. (1990) · Cancer · doi:10.1002/1097-0142(19900415)65:8<1864::aid-cncr2820650832>3.0.co;2-u · Cited by 361
Tobe, T., Uchino, J., Endo, Y., Oto, M., Okamoto, E., Kojiro, M., Shikata, T., Tanikawa, K., Tsuzuki, T., Mizumoto, R., et al. (1994) · Cancer · doi:10.1002/1097-0142(19941115)74:10<2772::aid-cncr2820741006>3.0.co;2-v · Cited by 335
Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis
Pateron, D., Ganne, N., Trinchet, J. C., Aurousseau, M. H., Mal, F., Meicler, C., Coderc, E., Reboullet, P., & Beaugrand, M. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80468-4 · Cited by 296
Ganne-Carrie, N., Chastang, C., Chapel, F., Munz, C., Pateron, D., Sibony, M., Deny, P., Trinchet, J., Callard, P., Guettier, C., et al. (1996) · Hepatology · doi:10.1002/hep.510230527 · Cited by 206
Llovet, J. M., Bruix, J., & Gores, G. J. (2000) · Hepatology · doi:10.1053/he.2000.6959 · Cited by 180
Chen, T. H., Chen, C., Yen, M., Lu, S., Sun, C., Huang, G., Yang, P., Lee, M., & Duffy, S. W. (2001) · International Journal of Cancer · doi:10.1002/ijc.10122 · Cited by 144
Small Hepatocellular Carcinoma: Detection with US, CT, MR Imaging, DSA, and Lipiodol-CT
Bartolozzi, C., Lencioni, R. A., Caramella, D., Palla, A., Bassi, A. M., & Candio, G. D. (1996) · Acta Radiologica · doi:10.1177/02841851960371p114 · Cited by 126
Ballardini, G., Groff, P., Zoli, M., Bianchi, G., Giostra, F., Francesconi, R., Lenzi, M., Zauli, D., Cassani, F., & Bianchi, F. P. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80061-3 · Cited by 64
Hcc Surveillance: Who Is the Target Population?
Bruix, J., & Llovet, J. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50142 · Cited by 52
Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Rodríguez, M. A. M., Rendón Unceta, P., Tejada Cabrera, M., et al. (2000) · PubMed · Cited by 17
Cited by
Microenvironmental regulation of tumor progression and metastasis
Quail, D. F., & Joyce, J. A. (2013) · Nature Medicine · doi:10.1038/nm.3394 · Cited by 7,994
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“On the other hand, cohort comparisons of 6 versus 12-month schemes provide similar results [52,92], while retrospective studies identified better performance of the 6-month interval in terms of stage migration (small HCC amenable for curative treatments) [96] and survival [97].”
ResultThe biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Metadata
- Authors
- Sangiovanni, A., Del Ninno, E., Fasani, P., De Fazio, C., Ronchi, G., Romeo, R., Morabito, A., de Franchis, R., & Colombo, M.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2004-04
- Volume
- 126
- Issue
- 4
- Pages
- 1005-1014
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2131212067
- Cited by
- 600
- References
- 23
- FWCI
- 21.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.